Colon Cancer Study Is Stopped

A late-stage study of the cancer drug Sutent as a treatment for colon cancer has been halted because the drug is not effective enough, the drug's manufacturer, Pfizer, announced Tuesday.

The study was designed to compare the use of a combination treatment of Sutent and a type of chemotherapy with use of the chemotherapy alone. Researchers found that the combination treatment was not more effective at extending survival without cancer progression.

There were no safety issues, according to Pfizer.

Sutent is approved in the United States for treatment of advanced kidney cancer and gastrointestinal cancer, the Associated Press reported.

More on This

• Most women with cancer want a role in decisions
• Cancer trial participants may have misconceptions
• Crab-like robot built to remove stomach cancer
• FDA approves BTG's drug for cancer toxicity

Tags

• Cancer
• Colorectal Cancer

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Do you really want to post anonymously?

Are You a Member? Log InConnect your comment to your member profile. It only takes a second! Not a Member? Join Now!You'lll be automatically notified when someone else comments on your post.

Tell us what you think Write your comment here *

Leave this field blank

Receive email notifications of new comments Email Addresss

Sign me up for EmpowHER's FREE Newsletter!

Type in the characters above *

By hitting submit, you agree to EmpowHER's terms of service and privacy policy